Akebia Therapeutics (AKBA) Assets (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Assets of $362.5 million for Q1 2026, up 16.87% year-over-year from $310.2 million in Q1 2025, and down 3.73% quarter-over-quarter from $376.6 million in Q4 2025.
Akebia Therapeutics (AKBA) Assets (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Assets for 14 consecutive years, with $362.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 16.87% year-over-year to $362.5 million; the TTM figure through Mar 2026 stood at $362.5 million (up 16.87% YoY), while the FY2025 annual figure was $376.6 million, up 70.65% from the prior year.
- Assets eased to $362.5 million in Q1 2026 per AKBA's latest filing, from $376.6 million in the prior quarter.
- Across five years, Assets topped out at $541.8 million in Q1 2022 and bottomed at $207.1 million in Q3 2024.
- Historically, Assets has averaged $324.5 million across 5 years, with a median of $310.2 million in 2025.
- Annual changes were most pronounced in 2023 — Assets sank 52.12% — and 2025, when it soared 75.8%.
- Akebia Therapeutics' Assets stood at $356.1 million in 2022, then tumbled by 32.12% to $241.7 million in 2023, then dropped by 8.7% to $220.7 million in 2024, then soared by 70.65% to $376.6 million in 2025, then fell by 3.73% to $362.5 million in 2026.
- Business Quant data shows AKBA's Assets at $362.5 million in Q1 2026, $376.6 million in Q4 2025, and $364.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 6.18 Bn |
| 10 | Akebia Therapeutics | 245.42 Mn | 89.87 Mn | 38.70 Mn | 349.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 349.66 Mn |
| Mar 31, 2026 | 362.52 Mn |
| Dec 31, 2025 | 376.57 Mn |
| Sep 30, 2025 | 364.15 Mn |
| Jun 30, 2025 | 345.60 Mn |
| Mar 31, 2025 | 310.19 Mn |
| Dec 31, 2024 | 220.67 Mn |
| Sep 30, 2024 | 207.14 Mn |
| Jun 30, 2024 | 220.20 Mn |
| Mar 31, 2024 | 225.48 Mn |
| Dec 31, 2023 | 241.70 Mn |
| Sep 30, 2023 | 235.00 Mn |
| Jun 30, 2023 | 253.71 Mn |
| Mar 31, 2023 | 280.93 Mn |
| Dec 31, 2022 | 356.05 Mn |
| Sep 30, 2022 | 444.25 Mn |
| Jun 30, 2022 | 529.88 Mn |
| Mar 31, 2022 | 541.80 Mn |
| Dec 31, 2021 | 529.35 Mn |
| Sep 30, 2021 | 602.27 Mn |